CATHERINE KAMAU: Open Payments
NPI 1275777955 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,712 in 106 payments from 20 companies in 2025. Trend: 2023 $2,806 · 2024 $2,059 · 2025 $2,712
Food & beverage: $2,712
| Company | Payments | Amount |
|---|---|---|
| LivaNova USA, Inc. | 10 | $583 |
| UCB, Inc. | 30 | $574 |
| Aucta Pharmaceuticals, Inc. | 20 | $441 |
| SK Life Science, Inc. | 7 | $192 |
| Teva Pharmaceuticals USA, Inc. | 9 | $160 |
| Neurelis, Inc. | 4 | $122 |
| JAZZ PHARMACEUTICALS INC. | 3 | $109 |
| SpringWorks Therapeutics, Inc. | 3 | $76 |
| ABBVIE INC. | 4 | $73 |
| PFIZER INC. | 3 | $66 |
Products named: VNS THERAPY SENTIVA MODEL 1000 GENERATOR, Motpoly XR, Fintepla, Briviact, VALTOCO, AUSTEDO XR, EPIDIOLEX, Nayzilam.
Industry payments across TX — which companies pay providers there.
